Latest News - Zoetis
Top Corporates Hub
Zoetis
2 of Wall Street’s Favorite Stocks on Our Watchlist and 1 We Brush Off
09.06.2026 12:30
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Zoetis (ZTS) Receives UK Approval for Long-Acting Osteoarthritis Pain Therapy Lenivia
08.06.2026 03:44
Zoetis Inc. (NYSE:ZTS) is one of the oversold stocks to buy right now. On May 28, Zoetis received approval from the UK’s Veterinary Medicines Directorate for Lenivia (izenivetmab), a new long-acting monoclonal antibody therapy for alleviating osteoarthritis pain in dogs. Administered as a single injection, the treatment targets nerve growth factor to provide effective pain […]
A Look At Zoetis (ZTS) Valuation After Guidance Cut Legal Actions And Companion Animal Headwinds
05.06.2026 01:08
Zoetis (ZTS) is back in focus after a cluster of securities class action filings, all tied to weakening demand, rising competition, and safety concerns in its flagship Companion Animal portfolio. See our latest analysis for Zoetis. At a share price of $79.52, Zoetis has seen short term volatility with a 1 day share price return of 2.49% and 7 day share price return of 1.60%. However, momentum has been weak over longer periods, with the 30 day share price return down 29.34%, the 90 day share...
Cattle Prices Are a Problem for Tyson and JBS Stock. Could New World Screwworm Make Things Worse?
04.06.2026 14:23
The parasitic fly has been detected in the U.S. for the first time in 60 years, putting pressure on an already shrinking cattle population.
Zoetis Releases 2025 Sustainability Report: Advancing Sustainability in Animal Health for a Better Future
04.06.2026 12:30
PARSIPPANY, N.J., June 04, 2026--Zoetis published its 2025 Sustainability Report, highlighting progress achieved in 2025 through its Driven to Care strategy. This report marks a significant milestone as Zoetis delivers on its initial aspirations set in 2021 and introduces its next phase with renewed focus across Communities, Animals, and the Planet.
Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?
02.06.2026 14:11
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Zoetis Inc. (NYSE:ZTS) is among the most undervalued stocks to invest in. TheFly reported on May 27 that Argus downgraded ZTS from Buy to Hold following a sharp decline in the company’s share price, including a steep one-day drop of about […]
Zoetis Lawsuits Challenge Companion Animal Outlook Yet Valuation Screens As Undemanding
02.06.2026 07:06
Multiple class action lawsuits and legal investigations have been filed against Zoetis (NYSE:ZTS) regarding its disclosures about the Companion Animal segment. The actions focus on claims that Zoetis misled investors about weakening growth, competitive pressures, and veterinarian adoption trends for key products. Allegations also reference safety concerns and market share losses in major Companion Animal offerings. Zoetis focuses on animal health products and services, with its Companion...
FedEx upgraded, Dollar General downgraded: Wall Street's top analyst calls
27.05.2026 13:35
FedEx upgraded, Dollar General downgraded: Wall Street's top analyst calls
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Agilent, Dollar General, FedEx, GE Aerospace, Hershey, Intuit, SanDisk, Workday, Zscaler, and More
27.05.2026 12:15
Pre-Market Stock Futures: Futures are trading higher as we hit the mid-week point, as the technology-led rally continues to spiral higher. While the major indices finished the day mixed, the technology-heavy Nasdaq led the way once again, closing at a new record high of 26,656, up 1.19%, while the S&P 500 also set a new ... Here Are Wednesday’s Top Wall Street Analyst Research Calls: Agilent, Dollar General, FedEx, GE Aerospace, Hershey, Intuit, SanDisk, Workday, Zscaler, and More
Argus Research Downgrades Zoetis to Hold
27.05.2026 07:51
Argus Research analyst Jasper Hellweg downgrades Zoetis (NYSE:ZTS) from Buy to Hold.
2 Profitable Stocks Worth Your Attention and 1 We Find Risky
22.05.2026 16:28
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Stifel Maintains Hold on Zoetis, Lowers Price Target to $95
22.05.2026 08:46
Stifel analyst Jonathan Block maintains Zoetis (NYSE:ZTS) with a Hold and lowers the price target from $105 to $95.
Zoetis Probe Tests Guidance Credibility And Long Term Investor Confidence
21.05.2026 14:09
Zoetis (NYSE:ZTS) is facing an investigation into potential securities fraud tied to a sharp guidance cut following earlier positive comments about its outlook. The probe focuses on whether prior statements about growth prospects were misleading and if investors received a full and timely picture of the company’s expectations. This development raises fresh questions about management credibility, disclosure practices, and possible legal and regulatory consequences for Zoetis. Zoetis focuses...
Zoetis to Participate in Upcoming Investor Conferences
21.05.2026 12:30
PARSIPPANY, N.J., May 21, 2026--Zoetis Inc. (NYSE:ZTS) today announced that a representative of the company will participate in fireside chats at the following investor conferences.
Wondering what's happening in today's after-hours session?
20.05.2026 21:00
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Zoetis Inc (NYSE:ZTS): A Dividend Growth Stock with Strong Profitability and Attractive Valuation
19.05.2026 11:30
Zoetis offers a strong dividend growth history and top profitability, with a 1.64% yield and P/E of 12.01, making it an attractive value play for income-focused investors.
Zoetis (ZTS) Valuation Reset After Q1 Earnings Miss And Guidance Cut
16.05.2026 14:12
Zoetis (ZTS) is under pressure after first quarter 2026 earnings missed analyst forecasts and management cut full year revenue and earnings guidance, highlighting softer U.S. companion animal demand and tougher competition in dermatology and pain. See our latest analysis for Zoetis. That weaker U.S. companion animal backdrop is showing up clearly in the share price, with Zoetis stock down about 38.5% on a 1 month share price basis and the 1 year total shareholder return declining roughly...
Jim Cramer Calls Zoetis a “Quality Company” Despite Recent Declines
14.05.2026 15:40
Zoetis Inc. (NYSE:ZTS) was one of the stocks on which Jim Cramer shared his take, explaining that dot-com analogies do not hold up in this market. Cramer highlighted the stock’s declines, as he said: Zoetis, okay, here’s a classic 1999er. The uber-consistent animal health company is experiencing something that’s pretty hard to believe: an endless […]
Here is Why Zoetis (ZTS) is One of the Best NYSE Stocks According Analysts
14.05.2026 11:33
Zoetis Inc. (NYSE:ZTS) is one of the best NYSE stocks to buy according to Wall Street analysts. On May 7, Zoetis reported Q1 2026 revenue of $2.3 billion, a 3% increase on a reported basis but flat organically. Net income reached $601 million, with adjusted diluted EPS growing 9% to $1.53. CEO Kristin Peck noted […]
Major Purchase Alert: MICHAEL MCCALLISTER Invests $233K In Zoetis Stock
13.05.2026 15:02
A notable insider purchase on May 12, was reported by MICHAEL MCCALLISTER, Director at Zoetis (NYSE:ZTS), based on the most recent SEC filing. What Happened: MCCALLISTER's recent purchase of 3,000 shares of Zoetis, disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday, reflects confidence in the company's potential. The total transaction value is $233,273. At Wednesday morning, Zoetis shares are down by 1.63%, trading at $75.69. Discovering Zoetis: A Closer Loo